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The question as to why major histocompatibility complex (MHC) a antigens are 
uniquely powerful primary immunogens and  in this respect differ from antigens of 
the minor systems has not yet been clearly answered. A  number of suggestions have 
been made in the past  (1-3), but they have not taken into account the remarkable 
variation  in  strength  with  which  MHC  antigens  induce  primary,  T-dependent 
responses,  depending  upon  how  the  antigens  are  presented.  In  some  strains,  for 
example, the donor tissue must  contain viable, metabolically active cells, although 
these need not necessarily be capable of cell division; thus x-irradiated lymphoid cell 
suspensions can provoke strong primary alloimmune responses, but ultra-violet irra- 
diated cells (4) or unfixed lymphocyte plasma membrane preparations (5) fail to do 
so,  even  though  they  carry  MHC  antigens  structurally  unaltered  insofar  as  they 
specifically absorb alloantibodies.  Furthermore, the donor tissue must  contain cells 
bearing MHC alloantigens of class II type (i.e., homologues of Ia for mouse and HLA- 
D/DR  for man);  thus,  incompatible rodent erythrocytes or platelets  fail to induce 
strong primary alloimmune responses  (6,  7),  although  they are  quite sufficient for 
inducing secondary (memory) responses. 
It has been previously shown  (8)  that  long-surviving, immunologically enhanced 
MHC-incompatible  rat  kidney  grafts,  when  retranspIanted  from  a  primary  to  a 
secondary recipient of the same genotype, do not elicit strong primary T-dependent 
alloimmunity in the secondary recipient. In contrast, normal primary kidney allografts 
in the relevant donor/recipient combination [(AS ×  AUG)F1 donor, AS recipient] do 
arouse strong primary T-dependent immunity, and the grafts are regularly rejected 
within  12 d  (8). The failure of long-surviving kidney grafts to activate T  helper cells 
cannot be attributed to an absence of either class I  or II MHC alloantigen because 
the grafts carry both  (9,  10).  We suggested that  the crucial difference between the 
long-surviving and normal kidney allografts that  accounted for the feeble immuno- 
genicity of the former was that the long-surviving grafts did not contain incompatible 
passenger  leukocytes.  The  experiments  described  in  this  report  show  that  strong 
immunogenicity can  be restored by injecting (AS  ×  AUG)Fx dendritic cells at  the 
time of retransplantation. The immunogenic effect of purified, viable T  or B lympho- 
cyte suspension  was  found to be at  least  2  log orders of magnitude  less  than  that 
provided by dendritic cells. The results suggest that MHC-incompatible allografts are 
1 Abbreviations  used in this  paper."  i.v.,  intravenous; MHC, major  histocompatibility  complex;  MLC, mixed 
lymphocyte  culture; PBS, phosphate-buffered  0.15 M saline. 
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uniquely powerful primary immunogens only if they also contain MHC-incompatible 
dendritic cells. The immunogenicity  of conventional macrophage populations lacking 
dendritic ceils or their precursors remains to be elucidated clearly, although our data 
points  to  their  having  only  weak  immunogenicity. With  this  qualification,  it  is 
suggested that MHC-incompatible tissues devoid of dendritic cells provoke responses 
comparable to those induced by minor system incompatibilities or the standard T- 
dependent protein antigens. 
Materials and Methods 
Animals.  We  used  the  following inbred rat  strains or  hybrids derived  from  them:  AS 
(RTIA  1) and AUG (RTIA  ~)  (11). The parental strains were bred at the National Institute for 
Medical Research, Mill Hill, England, and hybrids from them were bred in the experimental 
animal unit at this institution. All rats were maintained here. 
Kidney  Transplants and Retransplants.  These were  performed by conventional microsurgical 
technique, as previously described (8). Animals were inspected at regular intervals for survival 
and bled for serum urea estimations on days  7,  10,  14,  21, and 28.  Enhancement of (AS  X 
AUG)F1 kidneys transplanted into AS recipients was induced by means of a combined active 
and passive regime (12, 13) by injecting transplant recipients intravenously (i.v.) with 5 X  10  v 
donor strain spleen cells 11 d before kidney transplantation, 1 ml of AS anti-AUG strain anti- 
serum 1 d later, and a further I ml of the same anti-serum at the time of transplantation. 
Serum Ureas.  The glucose creatinine urea analyser 919 (Instrumentation Laboratories Ltd., 
Warrington, Cheshire, England) was used, using an area enzymatic rate reaction method on 
40-/11 samples. 
Preparation of T  Cell- and B  Cell-enriched Populations.  Lymphocytes were  derived from either 
peripheral blood by density centrifugation on Ficoll Hypaque (P ---  1.090) or from thoracic 
duct lymph. Enrichment for T  cells was  achieved by incubation of the cells on nylon wool 
columns and collecting the nonadherent cell population (14). B cell-enriched populations were 
prepared by incubating  neuraminidase (type VI; Sigma Chemical Co., St. Louis, Mo.)-treated 
cells on a  Helix Pomatia coupled Sepharose 6MB column (AB; Pharmacia Fine Chemicals, 
Div. of Pharmacia Inc., Piscataway, N.J.)  (15). To check that the enrichment procedures were 
satisfactory,  some samples of the T-enriched and the B-enriched cell suspensions were incubated 
with fluorescein  isothiocyanate-labeled anti-rat immunoglobulin, washed,  and examined by 
fluorescence  microscopy for the presence of lymphocytes with surface immunoglobulin.  T cell- 
enriched suspensions contained <10%,  and  B  cell  suspensions contained >80%  of surface 
immunoglobulin-postive  lymphocytes. 
Preparation of Macrophages.  Macrophages were obtained from a starting population of spleen 
or peritoneal exudate cells. Single cell spleen suspensions were obtained by in vivo and in vitro 
spleen digestion; collagenase (Sigma Chemical Co.,  type I,  75 mg/kg in ~ 1 ml of phosphate- 
buffered saline [PBS]) was injected i.v., and the rat was  killed  15 min later. The spleen was 
removed, diced into small pieces  (~0.04 cm  a) and rotated in RPMI  1640 medium containing 
protease from Bacillus polymyxa (Sigma Chemical Co.,  type  IX,  1 U/ml for 30 min at 37°C). 
After this, the cells were flushed through a metal sieve (pore size, 300/lm) and washed three 
times.  Macrophages were positively selected  from these  populations by adherence to Falcon 
plastic (Falcon Labware,  Div.  of Becton, Dickinson & Co.,  Oxnard, Calif.). The cells  were 
plated out  (~4 ×  107 cells/9-cm diam Falcon plastic petri dish; Falcon Labware)  in RPMI 
1640 medium supplemented with  YTc  fetal  calf serum.  After  l-h  incubation at  37°C,  the 
nonadherent cells  were  gently rinsed  with  warm  medium, and  fresh  medium was  added 
containing  0.6 mM EDTA. After a further 15-min incubation, the released adherent cells were 
vigorously pipetted off and washed.  The majority of cells had the morphological appearance of 
macrophages, but they were not tested for the presence of relevant surface marker antigens. 
Preparation of Dendritic Cells.  These cells were derived from thoracic duct afferent lymph, as 
described by Mason et  al.  (16). In brief, abdominal lymph nodes--mesenteric, para-aortic, 
renal, and coeliac--were removed from donor strain rats aged ~2 mo. After an interval of 6 wk, 
these rats were x-irradiated (700 rad), and thoracic duct cannulation  was performed within the 
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was  achieved by  a  density centrifugation step  (17).  Cells were  suspended  in  dense  bovine 
albumin, P =  1.084, overlayered with less dense albumin, P =  1.050, and centrifuged at 10,000 
g, 4°C, for 30 rain. The interface contained a population of 50-75% dendritic cells, judged by 
the striking morphological appearance of these cells. No tests for surface marker antigens were 
made. 
Measurement of the  Volume of Blood Contained in a Nephrectomized Rat Kidney.  Rat erythrocytes 
were washed and packed; to 1 ml packed cells was added 0.26 mC of SXCr in 20 p,l. After 15 min 
at room temperature the cells were washed, and  100 #1 of packed cells in  1 ml PBS  (emitting 
~ 106 CPM) was injected i.v. into each of three rats. After allowing 5 min equilibration time, 
the left renal vessels were clamped, and the left kidney was removed, blotted, and squeezed, as 
for transplantation. The  animals were bled from the aorta. Gamma-emissions from  1 ml of 
blood and the left kidney of each rat were measured in an LKB 1280 uhro-gamma spectrometer 
(LKB Instruments LTD., Surrey, England). The results are set out in Table I, The amount of 
blood transferred in a kidney graft varies according to the size of the kidney and how vigorously 
the kidney is blotted and  squeezed.  However, the normal  passenger blood volume of a  rat 
kidney weighing 1 g is ~0.1  ml when calculated from these results. In experiments to examine 
the immunogenicity of unfractionated blood cells, blood was withdrawn from heparin-treated 
(AS ×  AUG)F1 donors, and the plasma and excess heparin was removed after centrifugation. 
This procedure was found necessary to prevent persistent haemorrhage from the renal vascular 
anastamoses. 
Results 
Passenger cells in a  kidney allograft can be loosely divided into intravascular and 
extravascular components.  To  determine which  cells are  responsible for  the  strong 
primary immunogenicity characteristic of conventional kidney allografts, the follow- 
ing  experimental  design  was  used  throughout.  Long-surviving,  enhanced  (AS  × 
AUG)F1  kidneys residing in  AS  primary  recipients for >4  wk were  retransplanted 
into  secondary  AS  recipients.  Animals  receiving  retransplants  were  also  injected 
intravenously with cell subpopulations derived from  (AS ×  AUG)F1 donors. 
The  Effects  of  (AS  ×  A UG)Fa  Blood  on  the  Survival  of  Retransplanted  Kidney 
Allografls.  The rats in this experiment were injected with the cells from 0.1 or 0.5 ml 
of blood. Control rats received no blood. From Table II it can be seen that all animals 
given  0.1  ml  of blood,  i.e.,  the  amount  previously  demonstrated  to  be  contained 
within a  kidney prepared for transplantation, showed extended survival. Three out of 
the  four  rats  had  negligible rejection  episodes  and  were  killed after  3-4  mo.  The 
fourth (723) suffered a marked rejection episode but survived for over 4 wk. It appears 
that  the amount  of blood normally presented in a  kidney allograft does not  provide 
the  necessary  stimulus  for  graft  rejection.  When  as  much  as  0.5  ml  of blood  was 
injected, two out of four rats suffered acute graft destruction and all had sharp early 
rejection episodes. This suggests that although the amount of blood known to remain 
TABLE  I 
Calculation of Renal Passenger Blood Volume 
Blood volume 
Rat  1 ml Blood  Kidney  Kidney  Calculated  corrected to 
number  CPM  CPM  weight  blood volume  kidney weight 
oflg 
g  ml 
1  216,505  12,157  0.872  0.056  0.064 
2  164,564  19,540  1.078  0.119  0.110 
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TAnLE  II 
Survival and Function of (AS X  A UG)Fx Kidneys Retransplanted into Secondary AS Recipients Treated 
with (AS × AUG)F1 Blood Cells 
Rat  Serum urea 
Survival 
number  Day 0  Day 7  Day 10  Day 14  Day 21  Day 28 
mmol/  liter  d 
716"  10.5  6.5  10.0  9.0  7.5  8.0  >100 
717"  13.0  8.5  ND:~  13.8  15.0  14.0  >100 
718"  11.5  ND  29.0  15.5  12.5  12.5  > 100 
723*  10.0  12.0  >50  ND  26  83  29 
715§  9.0  7.0  50.0  22.5  12.0  13.5  >100 
720§  17.0  8.3  >50.0  --  --  --  12 
721§  10.6  8.1  >50.0  .....  11 
724§  12.0  7.4  44.0  22.0  22.0  18.0  > 100 
70111  9.5  8.0  11.8  8.5  11.0  10.9  >100 
703[I  14.2  8.8  12.0  8.0  8.0  ND  > 100 
71311  14.5  7.5  11.8  9.5  10.8  10.0  > 100 
714[[  9.5  9.0  14.5  11.2  10.5  10.8  >100 
71911  8.5  6.0  8.0  ND  8.0  10.0  >100 
*0.1 ml. 
:~ Not done, in this and all other tables. 
§ 0.05 rnl. 
II Controls not given  blood. 
in a kidney prepared for transplantation is insufficient to provoke graft destruction if 
given to the secondary recipient, blood does contain a  cell or cells in small numbers 
with this property. Their effect is demonstrated in the rats treated with 0.5 ml blood. 
The Effects of (AS ×  A UG)Fa Tand B Lymphocyte-enriched Suspensions on the Survival of 
Retransplanted Kidney Allografis.  These cell subpopulations were derived from either 
peripheral  blood  or  thoracic  duct  lymph, and  the  relevance of the  source  will  be 
referred to in the discussion section. In the T  cell-treated animals (Table III), two of 
seven rats given 2 million cells derived from blood died from acute graft rejection; the 
other five rats showed extended or indefinite survival, although two appear to have 
undergone a  transient rejection episode.  Prolonged survival was observed in all four 
animals  receiving  5  million  thoracic  duct  T  cells,  and  only  one  of  these  had  a 
significantly  elevated serum urea suggestive of a rejection episode. Furthermore, lower 
doses of T  cells (10  r') did not provoke acute graft destruction (data not shown). 
Two groups of rats were treated with cell suspensions of enriched B  lymphocytes 
(Table IV).  For  those  receiving 2  million cells,  the  source  before  enrichment was 
peripheral blood, and for those receiving 5 million cells, it was thoracic duct effluent. 
All the animals in these  groups have shown extended survival; one animal died at 
day 47  and the other  five are  likely to  enjoy indefinite survival as judged by their 
serum urea values. 
The Effects of (AS  X  A UG)F1 Adherent Cells on  the Survival of Retransplanted Kidney 
Altografis.  The method used to prepare adherent cell suspensions was subject to some 
variability between experiments, but  despite  this,  a  consistent effect  was  observed 
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TABLE  III 
Survival and Function of (AS X  A UG)F1 Kidneys Retransplanted into Secondary AS Recipients Treated 
with (AS ×  AUG)Ft T Cells 
Serum urea 
Rat number  Survival 
Day 0  Day 7  Day 10  Day 14  Day 21  Day 28 
retool/liter  d 
M30*  8.1  19. l  70.4  21.7  15.4  17.2  > 100 
M31*  10.1  ND$  10.9  21.4  14.8  13.3  >100 
M32"  11.1  11.1  21.8  13.5  21.3  12.8  >100 
M37"  11.0  6.6  74.4  --  --  --  l 1 
M40*  12.6  15.3  58.4  82.9  --  --  16 
M41"  9.9  7.4  45.9  28.3  14.8  26.1  28§ 
M42"  9.8  9.6  21.2  14.3  9.1  8.6  > 11210 
M481  17.2  7,3  55  27.5  42  24.0  47 
M491  10.7  7,1  11.0  14.5  11.5  11.7  >60 
M90II  10.4  6.5  ND  15.4  12.6  13.6  >28 
M91H  9.3  7.2  ND  11,9  10.1  8.9  >28 
* 2 ×  106 cells. 
:~ Not done. 
§ M41  killed  on day 28 because of large subcutaneous abscess.  The cause of death was infection. 
II 5 ×  106 cells. 
TABLE  IV 
Survival and Function of (AS X  A UG)Fa Kidneys Retransplanted into Secondary AS Recipients Treated 
with  (AS ×  AUG)FI B Cells 
Serum urea 
Rat number  Survival 
Donor  Day 7  Day 10  Day 14  Day 21  Day 28 
retool~liter  d 
M35"  8,0  6.9  32,7  12.2  NDJ~  13.0 (3 mo)  >100 
M38"  8.8  18.5  6.9  47.1  21.0  t 3.2  > 100 
M46"  8.2  8. l  20.4  15.4  18.3  27.5  >80 
M47"  11.6  6.5  22.4  10.8  13.8  14.0  47 
M94§  13.0  5.8  7.4  7.1  8.2  8.8  >42 
M95§  11.8  8.1  8. l  8.5  8.6  11.2  >42 
* 2 ×  10  6 cells. 
:~ Not done. 
§ 5 ×  106 cells. 
and three of four rats dying within  12 d  CFable  V). Similarly, in the group given 10  6 
adherent cells,  six of seven rats had a  very elevated serum urea at day 10, indicating 
rejection, although the survival times were extended in five rats and very prolonged 
in four. Only one early death occurred in the group of rats given 5 ×  10  5 cells,  and 
graft function was good in the  1st mo for the other three recipients. These data show 
that preparations of adherent cells  provide an immunogenic stimulus if 1 ×  10  6 to 2 
×  10  6 cells are given. 
Effects  of  (AS  X  AUG)F1  Dendritic Cells on  the  Survival of Retransplanted  Kidney 
Allografts.  As shown in Table VI, dendritic cells provide a  very potent stimulus to 
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TAnLE  V 
Survival and Function of (AS  ×  A UG)F~ Kidneys Retransplanted into Secondary AS Reapients  Treated 
with (AS ×  AUG)F1 Adherent Cells 
Rat  Serum urea 
Survival 
number  Donor  Day 7  Day 10  Day 14  Day 21  Day 28 
retool~liter  d 
M12s*  12.9  8.6  73.0  15.3  NDz~  19.0  >100 
Ml3s*  8.9  11.5  >80  --  --  --  i l 
M14s*  14.8  11.1  83.3  --  --  --  10 
M16s*  9.7  11.9  ....  i0 
M4p§  10.2  8.6  54  12. l  --  --  14 
M7p§  9.0  8.5  37.6  9.5  ND  35.6  66 
M9p§  13.2  8.0  69.8  18.7  46.9  28.6  > 100 
M 10p§  11~6  t4.9  10.5  17.6  t 9.6  ND  > 100 
M23s§  11.7  10.2  >83  --  --  --  10 
M24s§  10.3  14.4  >83  21.3  20.4  21.4  > 100 
M25s§  8.0  17.1  54.5  20.7  28.3  31.6  30 
M1 lp[[  12.8  ND  l 1.3  14.5  14.4  14.7  >100 
M 17s[[  17.0  6.8  9.4  ND  8.3  10.8  > 100 
M 18s[I  10.4  7.4  11.9  9.0  7.8  ND  54 
M20sl[  8.6  6.4  ....  10 
* 2 ×  106 cells. Postfix: s, splenic. 
Not done. 
§ 106 cells. Postfix: s, splenic;  p, peritoneal. 
11 5 ×  105 cells. Postfix: s, splenic;  p, peritoneal. 
5  ×  t04 or 105 cells. Eight of nine rats receiving the higher dose died within 2 wk, and 
at  the  lower dose,  all  animals  died  within  22  d.  Even  104  dendritic  cells exerted  an 
effect; two of the three recipients receiving this dose died at  12 and  22 d. 
The cell numbers in these groups refer to the morphologically identifiable dendritic 
cells removed from the albumin  interface. The remaining  25-50%  of cells have yet to 
be characterized  but  are probably  a  mixture of neutrophils  and  large lymphoblasts. 
As  a  specificity  control,  three  AS  rats  receiving  long-surviving  (AS  ×  AUG)F1 
kidneys  were  injected  intravenously  with  105  AS  strain  dendritic  cells.  The  re- 
transplanted  kidneys  were  not  acutely  rejected  and  all  these  rats  have  survived  for 
more than  1 too.  However, all three rats have been persistently uraemic from the 2nd 
wk. 
Discussion 
The main objective of our experiments was to identify the population(s)  of passenger 
cells  within  rat  kidney  allografts  which  confer  the  property  of activating  a  strong 
primary  alloimmune  response  leading  to  acute  graft  destruction.  Long-surviving, 
enhanced kidney grafts in the donor/recipient  combination  used here are not acutely 
rejected when  they are  retransplanted  into  a  secondary  recipient  syngeneic with  the 
primary  one  (8).  As  the  retransplanted  kidneys  are  assumed  to  be  devoid  of the 
original  donor  type  [i.e.,  (AS  ×  AUG)F1]  passenger  cells,  various  subpopulations  of 
(AS  ×  AUG)Fa  cells  likely  to  be  amongst  the  passengers  can  be  injected  into  the R.  I.  LECHLER  AND J.  R.  BATCHELOR  37 
TABLE  VI 
Survival and Function of (AS ×  A UG) Fx Kidneys Retransplanted into Secondary AS Recipients Treated 
with (AS ×  AUG)F1 Dendritic Cells 
Rat  Serum urea 
number  Survival 
Donor  Day 7  Day l0  Day  14  Day 21  Day 28 
mmol/  h'ter  d 
M61*  7.2  8.0  ....  10 
M62"  7.6  7.7  ....  10 
M63"  9.6  8.7  ....  10 
M65"  6.3  ND~:  82.9  --  --  --  10 
M67"  8.4  6.6  ....  10 
M68"  l 1.6  5.8  83,0  --  --  --  11 
M69"  8.2  5,7  >86  50.0  ND  51.0  42 
M70*  9.0  10.8  72.1  --  --  --  13 
M71*  8.4  15,4  73.5  --  --  --  12 
M72§  11.3  8.6  55.8  29.6  69.0  --  22 
M73§  8.8  6.9  69.5  29.8  --  --  20 
M75§  14.7  5.9  47.9  --  --  --  12 
M76[I  8.9  6.4  6.8  14.6  15.5  13.6  >56 
M77[]  9.6  7,4  79.7  --  --  --  12 
M78[[  10.7  6.2  15.9  42  59.6  --  22 
Specificity controls, secondary recipients treated with 105 AS dendritic cells 
M81  7.9  6.5  13.3  47.3  44.5  57.1  >28 
M82  10.0  6.4  16.5  33.8  46.5  59.8  >28 
M83  9.9  6.2  14.8  27.2  46.5  25.0  >28 
* 10  ~ cells. 
:~ Not done. 
§ 5 X 104 cells. 
II  104 cells. 
secondary  recipients  at  the  time  of  retransplantation  and  the  effect  on  allografl 
survival observed.  Our  results show  that  cell suspensions enriched  for  dendritic  cells 
are remarkably  effective in provoking acute graft destruction. The  minimum  number 
of cells required was ~1  ×  10  ~" to 5  ×  104, and, at a  dose of 105 dendritic  cells, all but 
one  of a  group  of nine  rats  destroyed  their  grafts  within  13  d.  This  acute  rate  of 
rejection is similar to that observed in conventional  allografts between  (AS ×  AUG)F1 
donors and  normal  AS strain recipients. The  degree of purity of the dendritic cells in 
the  suspensions  used  was  50-75%,  and  the  reservation  has  to  be  made  that  it  is 
possible but  unlikely that  another  cell that  has been copurified  is responsible for the 
results observed. 
In contrast to the effectiveness of dendritic cell suspensions, those enriched  for T  or 
B  cells were approximately  2  log orders of magnitude  less potent.  Because of the very 
powerful  immunogenicity  of  dendritic  cells,  we  cannot  be  certain  that  the  two 
examples  of acute  graft  rejection seen in the group  of 11  rats treated  with  2  ×  106 to 
5  ×  10  6  T  cells  were  not  due  to  incomplete  purification  of the  T  cell  suspension. 
Contamination  with  1-2%  dendritic  cells  or  their  precursors  could  be  sufficient  to 
initiate acute rejection. It is interesting that both examples of acute rejection occurred 38  DENDRITIC CELLS AND IMMUNOGENICITY OF  RAT KIDNEY GRAFTS 
in a  group of rats given T  cells purified from peripheral blood rather than  thoracic 
duct  lymph;  possibly,  this  reflects  differing  numbers  of  dendritic  cells  or  their 
precursors carried in blood and lymph. 
The inability of 5 ×  106 B lymphocytes to trigger acute graft rejection is important 
further evidence that the capacity of a cell to act as a strong primary alloimmunogen 
is not conferred by the mere presence of class II MHC molecules.  Rat  B cells carry 
~ 105 of these molecules per cell (18)  and dendritic cells carry -106 molecules per cell 
(16), so that additional factors other than the quantity of class II MHC molecules are 
implicated. 
Suspensions  of plastic adherent  spleen  or peritoneal  cells were clearly less active 
than dendritic cell suspensions. For example, only two of seven rats given 106 adherent 
cells died with acute graft destruction  during the first  2 wk after retransplantation. 
Although dendritic cells did not adhere strongly to plastic in our own experience and 
that of others (19), there is no data on their precursors, and possible contamination of 
the adherent cell suspensions with these cannot be assessed. 
The amount of intrarenal  blood remaining within  a  graft at  transplantation  was 
calculated to be 0.1  ml. Cells from this volume of blood failed to induce acute graft 
destruction,  and  the  results  are  consistent  with  the  conclusion  that  extravascular 
dendritic cells, known to be present in rat kidneys (20), are the major stimulus. 
The criteria for MHC-incompatible cells behaving as uniquely powerful primary 
immunogens in vivo have been mentioned earlier. These criteria are strikingly similar 
to the requirements necessary for a  positive response in  mixed lymphocyte cultures 
and  have led  to  the  view that  the  MLC  reaction  is  the  in  vitro equivalent  of the 
recognition  stage of primary immunization  by alloantigen  in  vivo  (21).  A  primary 
MLC  in  essence  provides  a  direct  measurement  of  cellular  proliferation  by  the 
responder TH cells.  Steinmann and colleagues (reviewed in 22)  and Mason et al. (16) 
have demonstrated that  dendritic  cells are extremely potent  stimulators of primary 
MLC reactions, and the lineage may be unique in this regard. Furthermore, Mason 
et al. (16), using purified TH cells as the responder population, have found that MHC- 
incompatible dendritic cells stimulate maximum responses. Our results indicate that 
allogeneic dendritic cells provide the major primary in vivo immunogenic stimulus of 
kidney allografts. It seems reasonable to conclude that the very reason for the powerful 
immunogenicity of these cells in vivo is because they directly activate the recipients' 
T~ cells. Although the three control AS rats that received passenger cell-depleted (AS 
×  AUG)Fa kidneys and  105 AS strain dendritic cells did not reject their grafts acutely 
within 2 wk (c.f. those that were given l0  b (AS ×  AUG)F1 dendritic cells), nevertheless, 
their serum urea levels were obviously raised from the second week onwards. Because 
even  syngeneic  dendritic  cells  can  stimulate  a  proliferative  response  in  vitro,  an 
interesting possibility is that syngeneic AS dendritic cells in vivo also can have a weak 
activating effect upon the recipient's helper T  cells. 
The donor/recipient  combination  used in  these experiments provides a  system in 
which the passenger cell-depleted kidney has a  greatly reduced immunogenicity and 
does not  provoke acute graft rejection.  In some other combinations, passenger cell- 
depleted kidneys can be rapidly rejected,  albeit without  the generation of cytotoxic 
antibodies (10). Our interpretation of this strain-dependent variability is that primary 
alloimmunization can occur by two routes  (Fig.  1).  By route  1, allogeneic dendritic 
cells present  in  MHC-incompatible tissues can  bypass the  need  for further antigen R.  I.  LECHLER  AND J.  R.  BATCHELOR 
DONOR  RECI  PIENT 
dendritic  cell 
dendritic cell 
and processed  ~" 
by recipient 
All  other ®nor  cells  (~]  ~)  ] activation 
(i.e., not dendritic  cells)  ~  J by route II 
J 
FIG.  1.  Dual  route of sensitization by alloantigen. Direct stimulation of Tn  (helper T  cells) by 
allogeneic dendritic cells leads to sensitization by route 1. Route 2, operative in the absence of donor 
strain  dendritic cells, involves the processing and  presentation of alloantigen by recipient strain 
accessory cells. 
39 
processing and presentation, directly activating relevant Tn clones of the recipient. 
Arguing from the results of MLC reactions, it would be predicted that this route of 
immunization only occurs where the incompatibility of the allogeneic dendritic cells 
involves class II MHC antigens. By route 2, MHC alloantigen of the graft other than 
that  expressed  on  the  donor's  dendritic  cells  is  processed  and  presented  by  the 
recipients' own accessory cells. The handling and presentation of MHC antigen to TH 
clones by this route does not differ significantly from that involved for minor system 
incompatibilities or the commonly used protein antigens. 
According to our hypothesis, the crucial distinction between MHC-incompatible 
grafts  and  all  other  types  of antigen  is  that  by  virtue of their  content  of viable 
dendritic cells, primary alloimmunization can proceed by route 1 as well as by route 
2. All other antigens activate TH clones only by route 2.  Route  1 is likely to be an 
optimally efficient method of activation. Although the detailed molecular mechanisms 
of the process remain uncertain, triggering of TH cells involves their recognition of an 
alteration to self in association with self class II MHC  substances  (23, 24). Class II 
MHC  molecules expressed by the  allogeneic dendritic ceils appear  to  provide the 
functional equivalent. Alloimmunization by route 1 would be optimally efficient not 
only  because  every  viable  allogeneic  dendritic  cell  would  express  the  functional 
trigger, but also because of the high density of the triggering molecules on each cell. 
Alloimmunization by route 2,  in  which  antigen  is  handled  by the  recipients' own 
accessory ceils, is most unlikely to lead to such a high density of altered self molecular 
triggers  on  the  recipients'  dendritic  cells.  Furthermore,  in  extreme antigen  excess, 
which  would  be  necessary  for  this  situation  to  develop,  there  would  also  be  the 
opportunity for activation of suppressor circuits. 
Returning  to the  problem  of the  strain-dependent  variation  in  survival  time of 
passenger cell-depleted kidney allografts transplanted  into secondary recipients, we 
would point out that acute graft destruction is not a precise measure of a  recipients' 
response. In those strain combinations where acute graft destruction does follow, no 40  DENDRITIC CELLS AND IMMUNOGENICITY OF  RAT KIDNEY  GRAFTS 
quantitative  comparison  has  been  made  to  determine  the  strength  of the  responses 
induced by ordinary allografts and those depleted of passenger cells.  Our prediction 
is that  MHC-incompatible,  passenger cell-depleted  kidney allografts immunize only 
by the relatively inefficient route II, and that in those combinations where such grafts 
are  acutely  rejected,  minimal  immunosuppression  at  levels  ineffective  for ordinary 
grafts would maintain  passenger cell depleted allografis in good function. 
Summary 
The immunogenicity of long-surviving, enhanced  (AS  ×  AUG)F1 renal  allografts 
retransplanted  into  secondary AS  recipients  was  restored  by the  injection  of small 
numbers of donor strain dendritic cells derived from afferent lymph. Whereas  1 ×  104 
to 5 X  104 dendritic cells were able to trigger an acute rejection response, neither the 
passenger volume of donor strain blood nor 5 .X  106 T  or B lymphocytes were able to 
do  so,  thereby  demonstrating  more  than  a  100-fold  difference  in  immunogenic 
potency. 
It  is  concluded  that  intrarenal  dendritic  cells  provide  the  major  immunogenic 
stimulus  of a  kidney  atlograft.  These  results  suggest  that  the  antigenic  strength  of 
major histocompatibility  complex-incompatible  tissue correlates  with  the content  of 
donor strain  dendritic  cells.  They also provide further evidence that  antigens  of the 
major histocompatibility complex behave like conventional  antigens unless  they are 
on the surface of allogeneic dendritic cells. 
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